Coronavirus News

Interventional Cardiology Market is Growing Strategically at a Healthy CAGR of 5.4% During Forecast to 2025

Market Analysis:


Various factors are adding to the global interventional cardiology market share. These factors, as per the new MRFR report, include increasing geriatric population, preference for minimally invasive procedures, growing awareness created by key players and medical professionals regarding the benefits of interventional cardiology procedures, increasing investment in R&D, incorporation of innovations in cardiac intervention industries, collaborations and partnerships between local players and key players, support by government organizations, and favorable reimbursement scenario especially in developed countries. Besides, increasing cases of cardiac disease and technological advances in interventional cardiac devices are also adding to the interventional cardiology devices market growth.


The Interventional Cardiology Market Trends  was valued USD 15,130.75 million in 2018 and is predicted to grow at a 5.4% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report. Interventional cardiology, simply put, is a branch of cardiology that deals with structural heart disease treatment that is catheter-based. 


Get a Free Sample @


On the contrary, the risk of bloodstream infections and product recalls are factors that may limit the interventional cardiology market growth over the forecast period.


Key Players:


  1. L. Gore & Associates, Inc. (US), Terumo Corporation (Japan), Merit Medical Systems, Inc (US), Medtronic (Ireland), Life Vascular Devices Biotech S.L. (Spain), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Edwards Lifesciences Corporation (US), Cook Medical (US), Cardinal Health (US), Boston Scientific Corporation (US), Biotronik SE & Co. KG (Germany), Biosense Webster, Inc (US), BD (US), B. Braun Melsungen AG (Germany), ACIST Medical Systems, Inc. (the US), Abbott (US), and ABIOMED (US). 


Market Segmentation:


  • The Market Research Future Report provides an inclusive segmental analysis of the global interventional cardiology marketbased on end user and type. 


  • By type, theinterventional cardiology market is segmented into coronary guidewires, plaque modification devices, percutaneous transluminal coronary angioplasty (PTCA) catheters, stents, and accessories. Stents are again segmented into bioresorbable vascular scaffolds, bare-metal stents, and drug-eluting stents. PTCA catheters are again segmented into guiding catheters and balloon catheters. Of these, the stents segment will lead the market over the forecast period for the rising number of product launches by industry players lately, constant innovation by players, and rising cases of coronary artery disease.


  • By end user, the interventional cardiology market is segmented into ambulatory surgical centers, cardiac catheterization laboratories, hospitals, and others. Of these, hospitals will spearhead the market over the forecast period for the increase in patient admissions in hospitals for coronary diseases. This will be followed by the cardiac catheterization laboratory segment, which is likely to grow at a fast pace for its rising preference by medical professionals.


Regional Analysis:

Based on the region, the global interventional cardiology market report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East & Africa (RoW). Of these, the Americas will spearhead the market over the forecast period for the rising prevalence of coronary diseases in the region. Besides, the presence of top market players is also adding market growth


The interventional cardiology market in Europe is predicted to possess the second-largest share over the forecast period for the rising number of hospitalizations for cerebral angioplasty and carotid artery angioplasty.


The interventional cardiology market in the APAC region is predicted to grow at a fast pace over the forecast period for an increasing number of collaborations and partnerships, rising number of setups of R&D centers, robust marketing initiatives undertaken by the manufacturers, and consumers helping to increase the target audience


The interventional cardiology market in the MEA is predicted to hold the smallest share over the forecast period yet is likely to grow owing to the focus of industry players on untapped regions.



NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Related Reports:

Myocardial Ischemia Market Research Report – Global Forecast till 2023

Transcatheter Market Research Report – Forecast to 2023